Arena Pharma (ARNA) Tops Q4 EPS by 24c

Arena Pharma (NASDAQ: ARNA) reported Q4 EPS of $0.16, $0.24 better than the analyst estimate of ($0.08). Revenue for the quarter came in at $85.4 million versus the consensus estimate of $15.58 million.

For earnings history and earnings-related data on Arena Pharma (ARNA) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Edible Garden AG (EDBL) Reports Q2 Loss of $18.79
• Movano (MOVE) Misses Q2 EPS by 195c